Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biogen to study Spinraza in combination with $2-mn Novartis drug
The one-a-day oral drug is viewed as a potential a rival to Spinraza, which is administered every four months via spinal infusion
Wave of promising study results raises hopes for coronavirus vaccines
Whether any of these efforts will result in a vaccine capable of protecting billions of people and ending the global pandemic that…
DHL Global Forwarding India opens temperature-controlled facility in Hyderabad
The new facility offers conditioning of packaging materials in different chambers for varying temperatures up to -20oC
Six people tests coronavirus positive in Maha FDA
A majority of them contracted the virus during field visits
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Serum to apply for local trials on Oxford’s vaccine in a week: CEO
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the…
FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of…
Over 158 applications for generic products pending with US FDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business…
OPTIMA launches GreenLution, a new sustainable capsule system
Working together with the companies Wipf and säntis packaging, Optima has developed a completely recyclable capsule system. It…